Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamineBianca M. Arendt, Johane P. Allard, David W.L. et al.|Applied Physiology Nutrition and Metabolism|2013Cited by 162
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Nadeem Anwar, Kathryn Jean Lucas et al.|Journal of Hepatology|2020Cited by 62